Caplans syndrome epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
| Line 15: | Line 15: | ||
*The [[prevalence]] of [[Caplan syndrome]] is estimated to be very low.<ref name="pmidPMID: 29763061.">{{cite journal| author=| title=StatPearls | journal= | year= 2021 | volume= | issue= | pages= | pmid=PMID: 29763061. | doi= | pmc= | url= }} </ref> | *The [[prevalence]] of [[Caplan syndrome]] is estimated to be very low.<ref name="pmidPMID: 29763061.">{{cite journal| author=| title=StatPearls | journal= | year= 2021 | volume= | issue= | pages= | pmid=PMID: 29763061. | doi= | pmc= | url= }} </ref> | ||
* Most recent study showed the prevalence of [[Caplan syndrome]] n Japan is 0.75% and in the USA it is 0.89%. No recent study on the prevalence in Europe. | * Most recent study showed the prevalence of [[Caplan syndrome]] n Japan is 0.75% and in the USA it is 0.89%. No recent study on the prevalence in Europe.<ref name="Benedek1973">{{cite journal|last1=Benedek|first1=Thomas G.|title=Rheumatoid pneumoconiosis|journal=The American Journal of Medicine|volume=55|issue=4|year=1973|pages=515–524|issn=00029343|doi=10.1016/0002-9343(73)90209-X}}</ref> | ||
<ref name="Benedek1973">{{cite journal|last1=Benedek|first1=Thomas G.|title=Rheumatoid pneumoconiosis|journal=The American Journal of Medicine|volume=55|issue=4|year=1973|pages=515–524|issn=00029343|doi=10.1016/0002-9343(73)90209-X}}</ref> | |||
===case-fatality rate/Mortality rate=== | ===case-fatality rate/Mortality rate=== | ||
Revision as of 22:16, 17 June 2021
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
|
Caplans syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Caplans syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Caplans syndrome epidemiology and demographics |
|
Risk calculators and risk factors for Caplans syndrome epidemiology and demographics |
Overview
The incidence of Caplan syndrome is 1 in 100,000 people but it is decreasing due to the reduction of exposure to coal, silica, and asbestos. Silica exposure has the most prevalence of Caplan syndrome.
Epidemiology and Demographics
Incidence
- Caplan syndrome is very rare in the United States. Incidence is currently 1 in 100,000 people but is likely to fall as the coal mining industry declines.[1]
Prevalence
- The prevalence of Caplan syndrome is estimated to be very low.[1]
- Most recent study showed the prevalence of Caplan syndrome n Japan is 0.75% and in the USA it is 0.89%. No recent study on the prevalence in Europe.[2]
case-fatality rate/Mortality rate
- Mortality rate in Caplan syndrome is very low except in association with black lung caused by coal worker pneumoconiosis.[3]
Age
- Caplan syndrome commonly affects individuals older than 18 years of age as Caplan syndrome is common in miners with exposure to coal, silica, asbestos, and other inhalable organic dust. [4]
Race
- There is no racial predilection to Caplan syndrome.
Gender
- There is no study available on gender.
Region
- The majority of Caplan syndrome cases are reported 0.75% in Japan and 1.5% in the United States.[5]
References
- ↑ 1.0 1.1 "StatPearls". 2021. PMID 29763061. PMID: 29763061. Check
|pmid=value (help). - ↑ Benedek, Thomas G. (1973). "Rheumatoid pneumoconiosis". The American Journal of Medicine. 55 (4): 515–524. doi:10.1016/0002-9343(73)90209-X. ISSN 0002-9343.
- ↑ Shaw, Megan; Collins, Bridget F.; Ho, Lawrence A.; Raghu, Ganesh (2015). "Rheumatoid arthritis-associated lung disease". European Respiratory Review. 24 (135): 1–16. doi:10.1183/09059180.00008014. ISSN 0905-9180.
- ↑ Alaya, Zeineb; Braham, Mouna; Aissa, Sana; Kalboussi, Houda; Bouajina, Elyès (2018). "A case of Caplan syndrome in a recently diagnosed patient with silicosis: A case report". Radiology Case Reports. 13 (3): 663–666. doi:10.1016/j.radcr.2018.03.004. ISSN 1930-0433.
- ↑ "Rheumatoid Pneumoconiosis: A Comparative Study of Autopsy Cases between Japan and North America". The Annals of Occupational Hygiene. 2002. doi:10.1093/annhyg/46.suppl_1.265. ISSN 1475-3162.